Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $321,194 | 175 | 84.5% |
| Food and Beverage | $29,200 | 1,672 | 7.7% |
| Travel and Lodging | $21,648 | 75 | 5.7% |
| Consulting Fee | $7,775 | 5 | 2.0% |
| Education | $104.24 | 4 | 0.0% |
| Grant | $43.95 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $98,488 | 382 | $0 (2024) |
| Amgen Inc. | $82,470 | 141 | $0 (2024) |
| Supernus Pharmaceuticals, Inc. | $54,540 | 191 | $0 (2022) |
| Lilly USA, LLC | $46,863 | 151 | $0 (2024) |
| Allergan, Inc. | $39,808 | 264 | $0 (2022) |
| Biohaven Pharmaceuticals, Inc. | $19,326 | 61 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $18,158 | 148 | $0 (2024) |
| Promius Pharma LLC | $7,102 | 32 | $0 (2019) |
| Avanir Pharmaceuticals, Inc. | $3,784 | 15 | $0 (2019) |
| EMD Serono, Inc. | $1,309 | 100 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $27,100 | 224 | ABBVIE INC. ($25,177) |
| 2023 | $19,808 | 194 | ABBVIE INC. ($18,094) |
| 2022 | $55,267 | 245 | ABBVIE INC. ($35,259) |
| 2021 | $71,765 | 310 | AbbVie Inc. ($19,958) |
| 2020 | $41,780 | 249 | Allergan, Inc. ($20,569) |
| 2019 | $53,701 | 228 | Amgen Inc. ($29,769) |
| 2018 | $51,766 | 245 | Amgen Inc. ($35,490) |
| 2017 | $58,778 | 237 | Supernus Pharmaceuticals, Inc. ($47,802) |
All Payment Transactions
1,932 individual payment records from CMS Open Payments — Page 1 of 78
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $18.87 | General |
| Category: Narcoplepsy | ||||||
| 12/20/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $17.61 | General |
| Category: Neurology | ||||||
| 12/20/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $1.29 | General |
| Category: Neurology | ||||||
| 12/19/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/19/2024 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $12.46 | General |
| 12/18/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $14.69 | General |
| Category: PAIN | ||||||
| 12/16/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $7.74 | General |
| Category: NEUROSCIENCE | ||||||
| 12/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.23 | General |
| Category: PAIN | ||||||
| 12/11/2024 | Life Molecular Imaging Ltd | NEURACEQ (Drug) | Food and Beverage | Cash or cash equivalent | $16.89 | General |
| Category: Diagnostic Tracer | ||||||
| 12/10/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $9.76 | General |
| Category: Central Nervous System | ||||||
| 12/09/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $21.31 | General |
| Category: Narcoplepsy | ||||||
| 12/09/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $1.79 | General |
| Category: Central Nervous System | ||||||
| 12/03/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.02 | General |
| Category: NEUROSCIENCE | ||||||
| 11/27/2024 | Teva Pharmaceuticals USA, Inc. | Austedo XR (Drug) | Food and Beverage | In-kind items and services | $5.74 | General |
| Category: Central Nervous System | ||||||
| 11/25/2024 | PFIZER INC. | ZAVZPRET (Drug) | Food and Beverage | In-kind items and services | $26.11 | General |
| Category: PAIN | ||||||
| 11/22/2024 | ABBVIE INC. | BOTOX (Biological), QULIPTA | Food and Beverage | In-kind items and services | $14.67 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 11/21/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $1.00 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | SK Life Science, Inc. | XCOPRI (Drug) | Food and Beverage | In-kind items and services | $19.61 | General |
| Category: Neurology | ||||||
| 11/11/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: NEUROSCIENCE | ||||||
| 11/05/2024 | ABBVIE INC. | UBRELVY (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | ABBVIE INC. | BOTOX (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: NEUROSCIENCE | ||||||
| 10/29/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $9.36 | General |
| Category: NEUROSCIENCE | ||||||
| 10/26/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: NEUROSCIENCE | ||||||
| 10/23/2024 | Lilly USA, LLC | EMGALITY (Drug), REYVOW | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 592 | 22,833 | $487,558 | $205,344 |
| 2022 | 11 | 610 | 21,747 | $429,289 | $185,393 |
| 2021 | 11 | 639 | 17,410 | $380,270 | $159,659 |
| 2020 | 11 | 592 | 17,064 | $307,939 | $139,729 |
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2023 | 45 | 20,645 | $149,615 | $102,416 | 68.5% |
| 64400 | Injection of anesthetic agent and/or steroid into face nerve | Office | 2023 | 73 | 516 | $145,942 | $44,834 | 30.7% |
| 64405 | Injection of anesthetic agent and/or steroid into upper neck and back of head nerve | Office | 2023 | 74 | 273 | $64,168 | $12,318 | 19.2% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2023 | 45 | 108 | $19,098 | $12,060 | 63.1% |
| 64450 | Injection of anesthetic agent and/or steroid into other nerve or branch | Office | 2023 | 74 | 278 | $53,556 | $11,296 | 21.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 45 | 78 | $11,232 | $6,693 | 59.6% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 76 | 274 | $20,164 | $6,225 | 30.9% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 50 | 77 | $7,922 | $4,587 | 57.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 20 | 20 | $7,390 | $2,934 | 39.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 13 | 13 | $3,923 | $1,520 | 38.8% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2023 | 77 | 551 | $4,548 | $459.27 | 10.1% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2022 | 36 | 19,795 | $145,765 | $90,769 | 62.3% |
| 64400 | Injection of anesthetic agent and/or steroid into face nerve | Office | 2022 | 66 | 428 | $110,988 | $37,711 | 34.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 87 | 157 | $22,760 | $11,806 | 51.9% |
| 64615 | Injection of chemical for paralysis of facial and neck nerve muscles on both sides of face | Office | 2022 | 34 | 103 | $18,817 | $10,502 | 55.8% |
| 64405 | Injection of anesthetic agent and/or steroid into upper neck and back of head nerve | Office | 2022 | 72 | 222 | $49,874 | $10,416 | 20.9% |
| 64450 | Injection of anesthetic agent and/or steroid into other nerve or branch | Office | 2022 | 75 | 229 | $41,642 | $9,480 | 22.8% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2022 | 72 | 225 | $16,218 | $5,154 | 31.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 61 | 91 | $9,529 | $5,086 | 53.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 15 | 15 | $5,265 | $2,367 | 44.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 15 | 15 | $4,599 | $1,699 | 36.9% |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 2022 | 77 | 467 | $3,832 | $402.14 | 10.5% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 29 | 15,450 | $112,350 | $72,517 | 64.5% |
| 64400 | Injection of anesthetic agent and/or steroid into trigeminal nerve of face | Office | 2021 | 58 | 355 | $100,631 | $29,340 | 29.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 103 | 162 | $22,938 | $14,233 | 62.0% |
About Dr. Faizan Hafeez, MD
Dr. Faizan Hafeez, MD is a Neurology healthcare provider based in Toledo, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1386630432.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Faizan Hafeez, MD has received a total of $379,965 in payments from pharmaceutical and medical device companies, with $27,100 received in 2024. These payments were reported across 1,932 transactions from 54 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($321,194).
As a Medicare-enrolled provider, Hafeez has provided services to 2,433 Medicare beneficiaries, totaling 79,054 services with total Medicare billing of $690,125. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Practice Information
- Specialty Neurology
- Location Toledo, OH
- Active Since 09/23/2005
- Last Updated 05/06/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1386630432
Products in Payments
- Aimovig (Biological) $81,178
- UBRELVY (Drug) $74,032
- TROKENDI XR (Drug) $54,540
- BOTOX (Biological) $45,765
- EMGALITY (Drug) $39,494
- NURTEC ODT (Drug) $20,641
- QULIPTA (Drug) $17,834
- AJOVY (Drug) $9,744
- Zembrace (Drug) $7,082
- AJOVY (Biological) $3,775
- ONZETRA Xsail (Drug) $2,943
- NUEDEXTA (Drug) $929.59
- Rebif (Biological) $613.43
- Briviact (Drug) $539.97
- RYTARY (Drug) $403.88
- VYEPTI (Biological) $397.83
- AUSTEDO (Drug) $328.46
- Mavenclad (Drug) $289.71
- GOCOVRI (Drug) $282.90
- Austedo XR (Drug) $276.24
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Toledo
Mr. Lawrence Elmer, M.d, M.D
Neurology — Payments: $795,067
Dr. Howard Schecht, Md, MD
Neurology — Payments: $293,155
Purvi Saraiya, Md, MD
Neurology — Payments: $31,205
Syed Zaidi, M.d, M.D
Neurology — Payments: $29,475
Dr. Gretchen Tietjen, M.d, M.D
Neurology — Payments: $20,256
Mrs. Jennifer Amsdell, M.d, M.D
Neurology — Payments: $17,470